Overview of monoclonal antibodies in cancer therapy: present and promise
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 54 (1), 11-29
- https://doi.org/10.1016/j.critrevonc.2004.10.011
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Trastuzumab-based combination therapy for breast cancerExpert Opinion on Pharmacotherapy, 2004
- Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaBlood, 2003
- Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceBlood, 2003
- Rituximab plus chemotherapy in follicular and mantle cell lymphomasSeminars in Oncology, 2003
- Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Blood, 2003
- Role of the adapter protein SLP-76 in GPVI-dependent platelet procoagulant responses to collagenBlood, 2002
- Level of CD 20-expression and Efficacy of Rituximab Treatment in Patients with Resistant or Relapsing B-cell Prolymphocytic Leukemia and B-cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2002
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- CD20: a regulator of cell-cycle progression of B lymphocytesImmunology Today, 1994
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982